Using immunotherapy can reduce risk of returning skin cancer - Study

A new study shows using an immunotherapy can significantly reduce the risk of a patient's skin cancer returning.

Nearly two thirds of of patients treated with nivolumab at an earlier stage alongside surgery, experienced recurrence-free survival.

Anne Gribben from Dublin was diagnosed with stage three malignant melanoma in 2006 and is still cancer-free as a result of the treatment.

She was given one of two drug treatment options and says her health has been great since.

She said: "The results have been good because everything has been clear since and I started that in 2015."

File image.

- Digital Desk

More in this Section

Footballer Jay Donnelly’s appeal against indecent image sentence adjourned

'Excruciatingly embarrassing' Garda Commissioner press conference was too long, says former Garda

'Take a day off work or school' to see total eclipse of the Moon, says Astronomy Ireland founder

Standards body to bring in new wiring rules for electricians by end of year


Fixing leeks in the cold snap

How some home truths can help save the planet

Wish List: Some delightfully eclectic products we need in our lives

Get smart about your bathroom with these app-based ecosystems

More From The Irish Examiner